2012 | |
---|---|
Criterium: | Position: |
Overall Score: | 900-1000 |
Networking Rank (Reputation): | 900-1000 |
Networking Rank (Reputation): | 900-1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 12.000.000 | 750.000 | 1 | ||
2012 | 0 | 10.941.665 | 30.602 | 1 | ||
2011 | 0 | 5.990.880 | 424.396 | 1 |
Total number of partners: 69
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 66
Frequent / Rare Partner Ratio: 0.05
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-02-01 | Heart OMics in AGEing | HOMAGE | participant | 12.000.000 | 18 |
2012-02-01 | European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke | EuroHYP-1 | participant | 10.941.665 | 38 |
2011-12-01 | Markers for Sub-Clinical Cardiovascular Risk Assessemnt | EU-MASCARA | participant | 5.990.880 | 16 |